| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |